SPDR® S&P Pharmaceuticals ETF (XPH) Annual Income Statement (USD)
XPH Quarterly Financials (USD)
Frequently Asked Questions About SPDR® S&P Pharmaceuticals ETF (XPH) Stock
SPDR® S&P Pharmaceuticals ETF's (XPH) last reported annual revenue was N/A.
SPDR® S&P Pharmaceuticals ETF's (XPH) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
SPDR® S&P Pharmaceuticals ETF's(XPH) is not profitable as of its last reported annual financials.
The net profit margin for SPDR® S&P Pharmaceuticals ETF's(XPH) from its laster reported year is N/A
The return on equity (ROE) for SPDR® S&P Pharmaceuticals ETF's(XPH) from its last reported annual financials is : N/A
The return on assets (ROA) for SPDR® S&P Pharmaceuticals ETF's(XPH) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for SPDR® S&P Pharmaceuticals ETF's(XPH) from its last reported annual financials is : N/A
The Debt to Equity ratio for SPDR® S&P Pharmaceuticals ETF's(XPH) from its last reported annual financials is : N/A
The dividend yield for SPDR® S&P Pharmaceuticals ETF's(XPH) from its laster reported year is N/A
SPDR® S&P Pharmaceuticals ETF's(XPH) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for XPH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
